Announcement of closure of the office
Dear patient,
I regret to inform you that as of November 1, 2024. after 51 years of practice in dermatology, I will retire and cease my practice at Centre Medical Lajeunesse, 552 Emile-Journault, Montreal H2M 1J7.
Patients requiring dermatology follow-up have already been referred to colleagues over the past two years. As for those who did not need follow-up during this period, but who do now, I recommend that you consult your general practitioner, who can refer you to a dermatologist if necessary.
You can also make an appointment with a doctor or other health professional via the Access Desk by dialing 811.
It was a great pleasure meeting you, and I wish you the best for the rest of your journey.
Antranik Benohanian, MD, FRCPC
|
|
HOME
|
|
|
|
|
ANTRANIK BENOHANIAN
MD, FRCP
Since 1978,
Dr. Benohanian has been treating hyperhidrosis with an extemporaneous
formulation consisting of topical aluminum chloride in a
salicylic acid gel. This formulation prevented many hyperhidrosis
victims from getting surgery. The gel is now available without prescription in all pharmacies across Canada under the name :
Hydrosal® Gel.
Dr. Benohanian
uses Botulinum Toxin type A with injections when topical treatments
fail to control focal hyperhidrosis (excessive sweating
of axillary, inguinal, craniofacial, palmar and plantar
regions). Botox injections on the armpits, groins and craniofacial
areas are usually well tolerated with little or no anesthesia.
For palmar and plantar hyperhidrosis, the procedure is much
more complex necessitating regional or general anesthesia
because of the densely innervated skin in those areas. Because
of that, many physicians are reluctant to treat palmar and
plantar hyperhidrosis.
Dr.Benohanian has elaborated a new technique to treat palmar
and plantar hyperhidrosis which involves painless needle-free
anesthesia, in tiny amounts (0.02 to 0.04 mL), prior to
Botox injection with needle. Needle free anesthesia is accomplished
through a device, specially tailored for that purpose: the
MED-JET manufactured by MIT Canada , a subsidiary of
Medical International Technology USA).
|
|
|
|
Conflict of interest
Antranik Benohanian MD is the owner of the following websites:
www.benohanian.com,
www.hyperhidrosis.ca &
www.hyperhidrose.ca . Dr. Benohanian has received
financial compensation from the following companies: Allergan and
Valeopharma for talks given on hyperhidrosis.
The information provided on this website is
designed to support, not replace, the relationship that exists
between a patient/site visitor and his/her dermatologist or treating
physician.
|
|
|